SCHEMBL13626540

SCHEMBL13626540

CN1CCCN(c2ccc(NC(=O)C3Cc4sccc4CN3C(=O)Nc3ccc(Cl)cc3)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 4/20 0.47
HTR1A P08908 1/20 0.44
HTR1D P28221 1/20 0.44
HTR1B P28222 1/20 0.44
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44
HTR6 P50406 1/20 0.44
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
MAPKAPK2 P49137 1/20 0.42
CA12 O43570 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
MAPT P10636 3/20 0.42
NPC1 O15118 1/20 0.41
NAMPT P43490 1/20 0.41
EGFR P00533 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13626550 0.87 NAMPT (0.51) F10HTR1AHTR1DHTR1BHTR2A
SCHEMBL13626549 0.87 NAMPT (0.51) F10HTR1AHTR1DHTR1BHTR2A
SCHEMBL13626504 0.87 NAMPT (0.51) F10HTR1AHTR1DHTR1BHTR2A
SCHEMBL13626555 0.85 F10 (0.49) F10HTR1AHTR1DHTR1BHTR2A
SCHEMBL13626535 0.79 LHCGR (0.39) F10LHCGR
SCHEMBL13626545 0.78 F10 (0.49) F10HTR1AHTR1DHTR1BHTR2A
SCHEMBL13626543 0.78 CFTR (0.41) F10LMNALHCGR
SCHEMBL13626569 0.78 LMNA (0.43) F10RAB9AKDM4ELMNAMAPT
SCHEMBL13626551 0.77 F10 (0.55) F10NAMPT
SCHEMBL13626564 0.75 F10 (0.54) F10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612089-B2 Tetrahydroisoquinolines as factor Xa inhibitors PORTOLA PHARMACEUTICALS, INC. (US) 2009-11-03 US disclosed
US-7612089-B2 Tetrahydroisoquinolines as factor Xa inhibitors PORTOLA PHARMACEUTICALS, INC. (US) 2009-11-03 US disclosed